← Eichor
Condition: Pulmonary Hypertension Ph Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pulmonary Hypertension Ph

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Phase N/A · 23 location(s) · Liquidia Technologies, Inc. · NCT06129240
Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT07120789
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Int
Phase 2 · 19 location(s) · AllRock Bio, Inc. · NCT07175038
The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
Phase N/A · 1 location(s) · University of Sao Paulo General Hospital · NCT07013149
Mobile Health Intervention to Improve Exercise in Pediatric PH
NA · 1 location(s) · Vanderbilt University Medical Center · NCT06549452
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · 92 location(s) · Tenax Therapeutics, Inc. · NCT07288398
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Phase 2 · 24 location(s) · Regeneron Pharmaceuticals · NCT07318597
The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
NA · 1 location(s) · University of Rochester · NCT07561034
Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes
Phase N/A · 1 location(s) · Guangdong Provincial People's Hospital · NCT07495774
A Trial of "APL-9796'' in Adults With Pulmonary Hypertension
Phase 2 · 6 location(s) · Apollo Therapeutics Ltd · NCT06846554
Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension U
Phase N/A · 1 location(s) · Istanbul Mehmet Akif Ersoy Educational and Training Hospital · NCT07522203
Bioenergetic Effect of Pioglitazone in CLD-PH
Phase 2 · 1 location(s) · Emory University · NCT06336798
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Phase 3 · 16 location(s) · Liquidia Technologies, Inc. · NCT07285655
Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
Phase N/A · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT07537517
PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
Phase N/A · 1 location(s) · University of Sao Paulo General Hospital · NCT06998329
CVD/PH and Voice Characteristics
Phase N/A · 1 location(s) · Mayo Clinic · NCT07311044
Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
NA · 1 location(s) · The Hospital for Sick Children · NCT05636397
Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients
Phase N/A · 1 location(s) · Medical University of Graz · NCT07498244
PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension
Phase N/A · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT07131241
Pulmonary Hypertension Observational Study
Phase N/A · 1 location(s) · The First Affiliated Hospital of Guangzhou Medical Universit · NCT05958901
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Phase 2 · 1 location(s) · Pulmovant, Inc. · NCT07333183
BPA in CTEPD Without PH
NA · 1 location(s) · Amsterdam UMC, location VUmc · NCT06090838
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease
Phase N/A · 67 location(s) · United Therapeutics · NCT06388421
Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)
Phase 2 · 9 location(s) · Foresee Pharmaceuticals Co., Ltd. · NCT06475781
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
NA · 1 location(s) · Children's Hospital of Philadelphia · NCT05442671
COMPERA / COMPERA-KIDS
Phase N/A · 7 location(s) · Technische Universität Dresden · NCT01347216
Feasibility of Novel Clinical Trial Infrastructure, Design and Technology for Early Phase Studies in Patients With Pulmo
Phase N/A · 1 location(s) · Sheffield Teaching Hospitals NHS Foundation Trust · NCT04078243
imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT06850792
Pulmonary Hypertension SOLAR
Phase 2 · 1 location(s) · Bastiaan Driehuys · NCT04778046
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Phase 2 · 5 location(s) · VA Office of Research and Development · NCT05937854
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.